Skip to main content
. 2019 Nov 1;33(21-22):1460–1474. doi: 10.1101/gad.326470.119

Figure 3.

Figure 3.

Nucleotide metabolism. Purine and pyrimidine biosynthesis are central to DNA replication and can be inhibited with antimetabolite drugs. In addition, the purine degradation activity of NT5C2, which contributes to resistance to 6-MP, sensitizes leukemia cells to inhibition of purine biosynthesis with mizoribine.